The role of trace elements in the pathogenesis of ocular surface diseases in type 2 diabetes mellitus: current concepts and clinical perspectives

Type 2 diabetes mellitus (T2DM) represents a significant risk factor for the development of ocular surface pathology, with the prevalence of dry eye syndrome, meibomian gland dysfunction, and chronic blepharitis exceeding that in the general population by 2–3 times. This review provides a comprehensive analysis of the role of trace element imbalance in the formation and progression of ocular surface diseases in T2DM. Particular attention is paid to the aspects of the influence of deficiency or excess of zinc, copper, selenium, magnesium, and iron on key pathogenetic links: oxidative stress, chronic inflammation, microangiopathy, neuropathy, and impaired reparative processes. Modern data on changes in the trace element profile in the systemic bloodstream, tear fluid, and meibomian gland secretion in patients with T2DM are systematized. The relationships between specific disorders of trace element homeostasis and clinical phenotypes of ocular surface damage are considered. Evidence is presented indicating that trace element imbalance acts not as a passive marker, but as an active participant in the pathological cascade, that determines the nature and severity of ophthalmic manifestations of T2DM. Promising research directions are outlined, including the development of methods for non-invasive assessment of the ocular surface trace element status, the creation of targeted correction tools, and the integration of the trace element approach into personalized algorithms for managing patients with diabetic eye involvement.

1. Shamsheer RP, Arunachalam C. A Clinical Study of Meibomian Gland Dysfunction in Patients with Diabetes. Middle East Afr J Ophthalmol. 2015;22(4):462–466. doi: https://doi.org/10.4103/0974-9233.167827

2. Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438–510. doi: https://doi.org/10.1016/j.jtos.2017.05.011

3. Goydin AP, Shutova SV, Fabrikantov OL. Evaluation of the diagnostic capabilities of nailfold capillaroscopy in diabetic retinopathy. Russian Annals of Ophthalmology. 2023;139(1):16–26. doi: https://doi.org/10.17116/oftalma202313901116

4. Batellier L, Chaumeil C, Moens C. Passage of proteins through the hemato-lacrimal barrier. Ophtalmologie. 1988;2(2):111–3.

5. Safonova TN, Zaitseva GV, Kintyukhina NP, Timoshenkova EI. Features of eyelid microcirculation in chronic mixed blepharitis and type 2 diabetes mellitus. Diabetes Mellitus. 2024;27(5):473–479. doi: https://doi.org/10.14341/DM13097

6. Zhou Q, Yang L, Wang Q, et al. Mechanistic investigations of diabetic ocular surface diseases. Front Endocrinol (Lausanne). 2022;13:1079541. doi: https://doi.org/10.3389/fendo.2022.1079541

7. Han SB, Yang HK, Hyon JY. Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging. 2018;14:53–63. doi: https://doi.org/10.2147/CIA.S190713

8. Morya AK, Ramesh PV, Kaur K, et al. Diabetes more than retinopathy, it’s effect on the anterior segment of eye. World J Clin Cases. 2023;11(16):3736–3749. doi: https://doi.org/10.12998/wjcc.v11.i16.3736

9. Oshitari T. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina. Int J Mol Sci. 2023;24(3):2927. doi: https://doi.org/10.3390/ijms24032927

10. Mussi N, Haque W, Robertson DM. The Association Between Risk Factors for Metabolic Syndrome and Meibomian Gland Disease in a Dry Eye Cohort. Clin Ophthalmol. 2021;15:3821–3832. doi: https://doi.org/10.2147/OPTH.S322461

11. Aloysius Dhivya M, Sulochana KN, Bharathi Devi SR. High glucose induced inflammation is inhibited by copper chelation via rescuing mitochondrial fusion protein 2 in retinal pigment epithelial cells. Cell Signal. 2022;92:110244. doi: https://doi.org/10.1016/j.cellsig.2022.110244

12. Cancarini A, Fostinelli J, Napoli L, et al. Trace elements and diabetes: Assessment of levels in tears and serum. Exp Eye Res. 2017;154:47–52. doi: https://doi.org/10.1016/j.exer.2016.10.020

13. Zoroddu MA, Aaseth J, Crisponi G, et al. The essential metals for humans: a brief overview. J Inorg Biochem. 2019;195:120–129. doi: https://doi.org/10.1016/j.jinorgbio.2019.03.013

14. Ruan S, Guo X, Ren Y, et al. Nanomedicines based on trace elements for intervention of diabetes mellitus. Biomed Pharmacother. 2023;168:115684. doi: https://doi.org/10.1016/j.biopha.2023.115684

15. Sanjeevi N, Freeland-Graves J, Beretvas SN, Sachdev PK. Trace element status in type 2 diabetes: a metaanalysis. J Clin Diagn Res. 2018;12(5):OE01–OE08. doi: https://doi.org/10.7860/JCDR/2018/35026.11541

16. Ugarte M, Osborne NN. Recent advances in the understanding of the role of zinc in ocular tissues. Metallomics. 2014;6(2):189–200. doi: https://doi.org/10.1039/c3mt00291h

17. Safonova TN, Pateyuk LS. Features of water-electrolyte component of the tear fluid. Russian Annals of Ophthalmology. 2023;139(1):106–113. (In Russ.) doi: https://doi.org/10.17116/oftalma2023139011106

18. Ugarte M, Osborne NN. Zinc in the retina. Prog Neurobiol. 2001;64(3):219–49. doi: https://doi.org/10.1016/s0301-0082(00)00057-5

19. Burke N, Butler JS, Flitcroft I, Loughman J. The relationship between serum zinc levels and myopia. Clin Exp Optom. 2021;104(1):28–34. doi: https://doi.org/10.1111/cxo.13069

20. Blasiak J, Pawlowska E, Chojnacki J, et al. Zinc and Autophagy in Age-Related Macular Degeneration. Int J Mol Sci. 2020;21(14):4994. doi: https://doi.org/10.3390/ijms21144994

21. Chu A, Foster M, Hancock D, et al. Interrelationships among mediators of cellular zinc homeostasis in healthy and type 2 diabetes mellitus populations. Mol Nutr Food Res. 2017;61. doi: https://doi.org/10.1002/mnfr.201600838

22. Skalnaya MG, Skalny AV, Tinkov AA. Serum copper, zinc, and iron levels, and markers of carbohydrate metabolism in postmenopausal women with prediabetes and type 2 diabetes mellitus. J Trace Elem Med Biol. 2017;43:46–51. doi: https://doi.org/10.1016/j.jtemb.2016.11.005

23. Nicolson TJ, Bellomo EA, Wijesekara N, et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009;58(9):2070–83. doi: https://doi.org/10.2337/db09-055141

24. Kinlaw WB, Levine AS, Morley JE, Silvis SE. Abnormal zinc metabolism in type II diabetes mellitus. J McClain Am J Med. 1983;75(2):273–7. doi: https://doi.org/10.1016/0002-9343(83)91205-6

25. Chen L, Xie Y, Yu C, et al. Enhanced fenton-like catalytic activity and stability of g-c3n4 nanosheet-wrapped copper phosphide with strong anti-interference ability: Kinetics and mechanistic study. J Colloid Interface Sci. 2021;595:129–141. doi: https://doi.org/10.1016/j.jcis.2021.03.122

26. Klevay LM. Ocular lesions from copper deficiency. Indian J Med Res. 2017;146(3):430–431. doi: https://doi.org/10.4103/ijmr.IJMR_246_17

27. Ou L, Wu Z, Hu X, et al. A tissue-adhesive F127 hydrogel delivers antioxidative copper-selenide nanoparticles for the treatment of dry eye disease. Acta Biomater. 2024;175:353–368. doi: https://doi.org/10.1016/j.actbio.2023.12.021

28. Jünemann AGM, Michalke B, Lucio M, et al. Aqueous humor selenium level and open-angle glaucoma. J Trace Elem Med Biol. 2018;50:67–72. doi: https://doi.org/10.1016/j.jtemb.2018.06.010

29. Al-Bassam L, Shearman GC, Brocchini S, et al. Potential of SeleniumBased Therapies for Ocular Oxidative Stress. Pharmaceutics. 2024;16(5):631. doi: https://doi.org/10.3390/pharmaceutics16050631

30. Flohé L. Selenium, selenoproteins and vision. Dev Ophthalmol. 2005;38:89–102. doi: https://doi.org/10.1159/000082770

31. Wang C, Ran R, Jin X, Zhu X. Plasma and vitreous selenium concentrations in patients with type 2 diabetes and diabetic retinopathy. Medicine (Baltimore). 2022;101(39):e30877. doi: https://doi.org/10.1097/MD.0000000000030877

32. Ugurlu A, Yılmaz H. Influences of Hypomagnesemia on Optic Nerve and Retinal Vascular Structure Determined Using Optical Coherence Tomography (OCT) Angiography. Curr Eye Res. 2021;46(4):579–584. doi: https://doi.org/10.1080/02713683.2020.1857779

33. Gong H, Takami Y, Kitaoka T, Amemiya T. Corneal changes in magnesium-deficient rats. Cornea. 2003;22(5):448–56. doi: https://doi.org/10.1097/00003226-200307000-00011

34. Gong H, Amemiya T, Takaya K. Retinal changes in magnesium-deficient rats. Exp Eye Res. 2001;72(1):23–32. doi: https://doi.org/10.1006/exer.2000.0928

35. Cekic O, Bardak Y Lenticular calcium, magnesium, and iron levels in diabetic rats and verapamil effect. Ophthalmic Res. 1998;30(2):107–12. doi: https://doi.org/10.1159/000055462

36. Goralska M, Ferrell J, Harned J, et al. Iron metabolism in the eye: a review. Exp Eye Res. 2009;88(2):204–15. doi: https://doi.org/0.1016/j.exer.2008.10.026

37. Sobieska K, Buczyńska A, Krętowski AJ, Popławska-Kita A. Iron homeostasis and insulin sensitivity: unraveling the complex interactions. Rev Endocr Metab Disord. 2024;25(5):925–939. doi: https://doi.org/10.1007/s11154-024-09908-7

38. Chen YJ, Chen JT, Tai MC, et al. Serum Iron and Risk of Diabetic Retinopathy. Nutrients. 2020;12(8):2297. doi: https://doi.org/10.3390/nu12082297

39. Seyyar SA, Tokuç EÖ, Soysal GG. Effect of diabetic macular oedema on serum iron status indicators. Clin Exp Optom. 2024;107(3):313–317. doi: https://doi.org/10.1080/08164622.2023.2218997

40. Liu B, Feng W, Wang J, et al. Association of urinary metals levels with type 2 diabetes risk in coke oven workers. Environ Pollut. 2016;210:1–8. doi: https://doi.org/10.1016/j.envpol.2015.11.046

41. Kuo YK, Shao SC, Lin ET, et al. Tear function in patients with diabetes mellitus: A systematic review and metaanalysis. Front Endocrinol (Lausanne). 2022;13:1036002. doi: https://doi.org/10.3389/fendo.2022.1036002

42. Nagar S, Ajouz L, Nichols KK, et al. Relationship Between Human Meibum Lipid Composition and the Severity of Meibomian Gland Dysfunction: A Spectroscopic Analysis. Invest Ophthalmol Vis Sci. 2023;64(10):22. doi: https://doi.org/10.1167/iovs.64.10.22

43. Ho E, Quan N, Tsai YH, et al. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med (Maywood). 2001;226(2):103–11. doi: https://doi.org/10.1177/153537020122600207

44. Ghasemi H, Gharebaghi R, Heidary F. Diabetes as a possible predisposer for blepharitis. Can J Ophthalmol. 2008;43(4):485. doi: https://doi.org/10.3129/i08-074